Home
News
Create
Screeners
Insights
Gufic BioSciences
317.
10
+3.70
(+1.18%)
Market Cap
₹3,179.96 Cr
PE Ratio
55.01
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.18%
1M
-0.67%
6M
-12.22%
1Y
-23.27%
5Y
+171.96%
View Company Insights
Latest news about Gufic BioSciences
Gufic Biosciences Schedules Q3FY26 Earnings Conference Call for February 16, 2026
3 hrs ago
Today
Gufic Biosciences Limited has scheduled its Q3FY26 earnings conference call for February 16, 2026 at 04:30 PM IST. The company has notified BSE and NSE under Regulation 30 of SEBI Listing Obligations about this investor engagement. Company officials will discuss business prospects and financial performance while taking questions from investors and analysts. Multiple international dial-in numbers and pre-registration options have been arranged for participant access.
Gufic Biosciences Receives Income Tax Demand of ₹4.33 Crores for Assessment Year 2024-25
Jan 20, 2026
Gufic Biosciences Receives GST Penalty Order of ₹15.64 Lakh for FY2018-19 to FY2022-23
Dec 27, 2025
Gufic Biosciences Reports Q1 Results: Revenue Up, Profit Down Amid Rising Costs
Aug 13, 2025
Gufic Biosciences Reports Mixed Q4 Results: Revenue Up, Profits Down
May 30, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation